Loading…

Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factor...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cardiovascular medicine 2024-06, Vol.11, p.1419001
Main Authors: Nguyen, Maxime, Putot, Alain, Masson, David, Cottin, Yves, Gautier, Thomas, Tribouillard, Laura, Rérole, Anne-Laure, Guinot, Pierre-Grégoire, Maza, Maud, Pais de Barros, Jean-Paul, Deckert, Valérie, Farnier, Michel, Lagrost, Laurent, Zeller, Marianne
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3
container_end_page
container_issue
container_start_page 1419001
container_title Frontiers in cardiovascular medicine
container_volume 11
creator Nguyen, Maxime
Putot, Alain
Masson, David
Cottin, Yves
Gautier, Thomas
Tribouillard, Laura
Rérole, Anne-Laure
Guinot, Pierre-Grégoire
Maza, Maud
Pais de Barros, Jean-Paul
Deckert, Valérie
Farnier, Michel
Lagrost, Laurent
Zeller, Marianne
description There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI. Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission. Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes. In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.
doi_str_mv 10.3389/fcvm.2024.1419001
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147</doaj_id><sourcerecordid>3077993395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</originalsourceid><addsrcrecordid>eNpVkU9vEzEQxVcIRKvSD8AF-cglwX_X9gmhCmilSkgIJC7ImtizqcvuOthOoN--DglVe_LI895vZvS67jWjSyGMfTf43bTklMslk8xSyp51p5xbvaBK_Xj-qD7pzku5pU2hpFG9edmdNL-RQtrT7ufXWH6RAXxNuRCYA9nktJ5TqdGTHYxbJGkgOIdU01-cIpA4kw3UiHMt5E-sNwT8tiKZ7pKHHCKMTTFA9jWm-VX3YoCx4PnxPeu-f_r47eJycf3l89XFh-uFF9LUhZLoMQgRjEbjGQfZdmW6BzUIb61ALnvaA1txG3QwqKFXgYLqhUC0EsVZd3XghgS3bpPjBPnOJYju30fKawe5XTSiY7whKeWoBypNsKanaIJHqVYDZ1I31vsDa7NdTdg6c80wPoE-7czxxq3TzrGG5karRnh7JOT0e4uluikWj-MIM6ZtcYJq3a4Sdi9lB6nPqZSMw8McRt0-ZreP2e1jdseYm-fN4wUfHP9DFffVGqWu</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3077993395</pqid></control><display><type>article</type><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><source>Open Access: PubMed Central</source><creator>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</creator><creatorcontrib>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</creatorcontrib><description>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI. Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission. Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes. In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</description><identifier>ISSN: 2297-055X</identifier><identifier>EISSN: 2297-055X</identifier><identifier>DOI: 10.3389/fcvm.2024.1419001</identifier><identifier>PMID: 38984349</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>acute myocardial infarction ; Cardiovascular Medicine ; diabetes ; endotoxemia ; inflammation ; lipopolysaccharide ; lipoprotein</subject><ispartof>Frontiers in cardiovascular medicine, 2024-06, Vol.11, p.1419001</ispartof><rights>2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller.</rights><rights>2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller. 2024 Nguyen, Putot, Masson, Cottin, Gautier, Tribouillard, Rérole, Guinot, Maza, Pais de Barros, Deckert, Farnier, Lagrost and Zeller</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232875/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232875/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38984349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Maxime</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><creatorcontrib>Masson, David</creatorcontrib><creatorcontrib>Cottin, Yves</creatorcontrib><creatorcontrib>Gautier, Thomas</creatorcontrib><creatorcontrib>Tribouillard, Laura</creatorcontrib><creatorcontrib>Rérole, Anne-Laure</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><creatorcontrib>Maza, Maud</creatorcontrib><creatorcontrib>Pais de Barros, Jean-Paul</creatorcontrib><creatorcontrib>Deckert, Valérie</creatorcontrib><creatorcontrib>Farnier, Michel</creatorcontrib><creatorcontrib>Lagrost, Laurent</creatorcontrib><creatorcontrib>Zeller, Marianne</creatorcontrib><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><title>Frontiers in cardiovascular medicine</title><addtitle>Front Cardiovasc Med</addtitle><description>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI. Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission. Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes. In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</description><subject>acute myocardial infarction</subject><subject>Cardiovascular Medicine</subject><subject>diabetes</subject><subject>endotoxemia</subject><subject>inflammation</subject><subject>lipopolysaccharide</subject><subject>lipoprotein</subject><issn>2297-055X</issn><issn>2297-055X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU9vEzEQxVcIRKvSD8AF-cglwX_X9gmhCmilSkgIJC7ImtizqcvuOthOoN--DglVe_LI895vZvS67jWjSyGMfTf43bTklMslk8xSyp51p5xbvaBK_Xj-qD7pzku5pU2hpFG9edmdNL-RQtrT7ufXWH6RAXxNuRCYA9nktJ5TqdGTHYxbJGkgOIdU01-cIpA4kw3UiHMt5E-sNwT8tiKZ7pKHHCKMTTFA9jWm-VX3YoCx4PnxPeu-f_r47eJycf3l89XFh-uFF9LUhZLoMQgRjEbjGQfZdmW6BzUIb61ALnvaA1txG3QwqKFXgYLqhUC0EsVZd3XghgS3bpPjBPnOJYju30fKawe5XTSiY7whKeWoBypNsKanaIJHqVYDZ1I31vsDa7NdTdg6c80wPoE-7czxxq3TzrGG5karRnh7JOT0e4uluikWj-MIM6ZtcYJq3a4Sdi9lB6nPqZSMw8McRt0-ZreP2e1jdseYm-fN4wUfHP9DFffVGqWu</recordid><startdate>20240625</startdate><enddate>20240625</enddate><creator>Nguyen, Maxime</creator><creator>Putot, Alain</creator><creator>Masson, David</creator><creator>Cottin, Yves</creator><creator>Gautier, Thomas</creator><creator>Tribouillard, Laura</creator><creator>Rérole, Anne-Laure</creator><creator>Guinot, Pierre-Grégoire</creator><creator>Maza, Maud</creator><creator>Pais de Barros, Jean-Paul</creator><creator>Deckert, Valérie</creator><creator>Farnier, Michel</creator><creator>Lagrost, Laurent</creator><creator>Zeller, Marianne</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240625</creationdate><title>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</title><author>Nguyen, Maxime ; Putot, Alain ; Masson, David ; Cottin, Yves ; Gautier, Thomas ; Tribouillard, Laura ; Rérole, Anne-Laure ; Guinot, Pierre-Grégoire ; Maza, Maud ; Pais de Barros, Jean-Paul ; Deckert, Valérie ; Farnier, Michel ; Lagrost, Laurent ; Zeller, Marianne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute myocardial infarction</topic><topic>Cardiovascular Medicine</topic><topic>diabetes</topic><topic>endotoxemia</topic><topic>inflammation</topic><topic>lipopolysaccharide</topic><topic>lipoprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Maxime</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><creatorcontrib>Masson, David</creatorcontrib><creatorcontrib>Cottin, Yves</creatorcontrib><creatorcontrib>Gautier, Thomas</creatorcontrib><creatorcontrib>Tribouillard, Laura</creatorcontrib><creatorcontrib>Rérole, Anne-Laure</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><creatorcontrib>Maza, Maud</creatorcontrib><creatorcontrib>Pais de Barros, Jean-Paul</creatorcontrib><creatorcontrib>Deckert, Valérie</creatorcontrib><creatorcontrib>Farnier, Michel</creatorcontrib><creatorcontrib>Lagrost, Laurent</creatorcontrib><creatorcontrib>Zeller, Marianne</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Maxime</au><au>Putot, Alain</au><au>Masson, David</au><au>Cottin, Yves</au><au>Gautier, Thomas</au><au>Tribouillard, Laura</au><au>Rérole, Anne-Laure</au><au>Guinot, Pierre-Grégoire</au><au>Maza, Maud</au><au>Pais de Barros, Jean-Paul</au><au>Deckert, Valérie</au><au>Farnier, Michel</au><au>Lagrost, Laurent</au><au>Zeller, Marianne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction</atitle><jtitle>Frontiers in cardiovascular medicine</jtitle><addtitle>Front Cardiovasc Med</addtitle><date>2024-06-25</date><risdate>2024</risdate><volume>11</volume><spage>1419001</spage><pages>1419001-</pages><issn>2297-055X</issn><eissn>2297-055X</eissn><abstract>There is increasing evidence regarding the association between endotoxemia and the pathogenesis of atherosclerosis and myocardial infarction (MI). During the acute phase of MI, endotoxemia might increase inflammation and drive adverse cardiovascular (CV) outcomes. We aimed to explore the risk factors and prognostic value of endotoxemia in patients admitted for acute MI. Patients admitted to the coronary care unit of Dijon University Hospital for type 1 acute MI between 2013 and 2015 were included. Endotoxemia, assessed by plasma lipopolysaccharide (LPS) concentration, was measured by mass spectrometry. Major adverse CV events were recorded in the year following hospital admission. Data from 245 consecutive MI patients were analyzed. LPS concentration at admission markedly increased with age and diabetes. High LPS concentration was correlated with metabolic biomarkers (glycemia, triglyceride, and total cholesterol) but not with CV (troponin Ic peak and N-terminal pro-brain natriuretic peptide) or inflammatory biomarkers (C-reactive protein, IL6, IL8, and TNFα). LPS concentration was not associated with in-hospital or 1-year outcomes. In patients admitted for MI, higher levels of endotoxins were related to pre-existing conditions rather than acute clinical severity. Therefore, endotoxins measured on the day of MI could reflect metabolic chronic endotoxemia rather than MI-related acute gut translocation.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38984349</pmid><doi>10.3389/fcvm.2024.1419001</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2297-055X
ispartof Frontiers in cardiovascular medicine, 2024-06, Vol.11, p.1419001
issn 2297-055X
2297-055X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_123c9002e7f048d9860e8dce45bf2147
source Open Access: PubMed Central
subjects acute myocardial infarction
Cardiovascular Medicine
diabetes
endotoxemia
inflammation
lipopolysaccharide
lipoprotein
title Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20and%20prognostic%20value%20of%20endotoxemia%20in%20patients%20with%20acute%20myocardial%20infarction&rft.jtitle=Frontiers%20in%20cardiovascular%20medicine&rft.au=Nguyen,%20Maxime&rft.date=2024-06-25&rft.volume=11&rft.spage=1419001&rft.pages=1419001-&rft.issn=2297-055X&rft.eissn=2297-055X&rft_id=info:doi/10.3389/fcvm.2024.1419001&rft_dat=%3Cproquest_doaj_%3E3077993395%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-54eced33d87e8c12a4015176a5f3c993e24606a1b29d7d8e7a65d0a5633ee94e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3077993395&rft_id=info:pmid/38984349&rfr_iscdi=true